Residents of India's slums think they are in vaccination like others, but in a part of a clinical trial.

Abstract: One health care worker was one of the largest COVID-19 vaccination activities in the world of India on January 16, 2021. She received a COVID-19 vaccine, which is a COVID-19 vaccine. A vaccine in Indi...

One health care worker was one of the largest COVID-19 vaccination activities in the world of India on January 16, 2021. She received a COVID-19 vaccine, which is a COVID-19 vaccine. A vaccine in India, January 16, 1921. Danish Siddiqui / Reuters  When a white Vatic is driving in the street advertisement, the Babar slum in the central India seems to be a win-win, "e taking coronavirus vaccine and gets 750 rupees!" Get from the speaker system 750 rupee.
But according to a new report of CNN, the shootback is part of the third stage of the COVAXIN clinical trial in India? Most recipients don't know some of their medical research now.  Covaxin is the first proprietary COVID-19 vaccine in India. The vaccine has not yet been fully approved public use, and currently approves the approval of restrictive emergency use. As of the end of January, Bharat Biotech stored more than 20 million Covaxin and pushed 700 million before 2021.
 Many people in vaccina through the valerian in Shankar Nagar Slum, only a few miles from 1984 industrial D, isasted will be estimated to be 500,000 people in poisonous gas clouds. Some of the locals in the region still report health problems in the incidents after ten years.
 CNN received 21 people who received the lens in the trial. Many people said that due to the commitment of 750 rupees, it is approximately the US commitment that they are attracted to the vaccine.
. "In any case, we are accustomed to death ... my life is worthless.  Public health experts said that the morality of 750 rupees is suspicious, especially if it is used to bring more volunteers. Incentives.
 Arun Shrivastav, headed in the pharmacology department of Boapal Gandilde Medical College, telling CNN if the country has promoted 750 rupees, which will be "unethical" and "complete mistakes".
"If this happens, then it cannot be calculated in the trial, the trial will be banned," SHRIVastav told CNN.  
Anil Kumar Dixit, the Dean of the Medical College and Boba's Research Center affirmed that his hospital paid a 750 rupee, but it was just to cover any missed salary, and Not as an incentive.  Many participants told CNN they didn't know that they didn't know that they might received placebo vaccine.
 Dixit tells CNN, everyone is in Olved very clear the lens is part of the trial, but more than half of the RMB CNN and illiterate speech, unable to read any of the provision of any instructions or health officials provided.
 For those who are unable to read, he said that officials explained everything in Hindi or English before the participant signed any form.
Many Bobal participants noticed that they did not ask the underlying health trial. A pregnant woman told CNN that she received the first injection before she was transferred to the second agent during pregnancy.  According to the University of John Hopkins, India is the fourth world of COVID-19 death, recording more than 156,000 people.
 The country is driving its health care worker vaccination, but medical workers continue to refuse local vaccines. According to Al Jazera, India vaccinated more than 1 million medical professionals, but only 11% of them agreed to take Covaxin shooting. The rest of the Astrazeneca vaccine.

Comments from netizens

0comments